Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

Tools& Resources

My daughter Capri and I on vacation in New Buffalo Michigan
Blog Post

MDA Ambassador Guest Blog: Finding My Way to a Sober and Healthy Way of Living

By Cassidy Nilles | March 4, 2025
Blog Post

Accommodations and Independence: Spreading My Wings on Campus

By Sydney Bryant | March 1, 2025
Blue 3d DNA molecule helix with red and yellow pancreas. Genetic diseases of the pancreas, DNA damage, genetic research concept. Low poly futuristic style. Abstract wireframe light structure. Vector
Blog Post

Simply Stated: Updates in Pompe Disease and Other Glycogen Storage Diseases

By Sujatha Gurunathan | February 27, 2025
Blog Post

MDA’s Development Grants Support Promising Researchers Entering the Neuromuscular Field

By Amy Bernstein | February 26, 2025
Black and white photo of Paul Cohen in a suit jacket and tie sitting in a desk chair
Blog Post

MDA’s Origin Story: A Grassroots Legacy

By MDA Staff | February 19, 2025
Blog Post

2024 MDA Advocacy Collaboration Grantees are Working Towards Change

By Jori Houck | February 13, 2025
Blog Post

Quest Podcast: Navigating Romance with MDA Ambassadors

By MDA Staff | February 13, 2025
Creatine kinase (CK), also known as creatine phosphokinase (CPK) or phosphocreatine kinase, is an enzyme expressed by various tissues and cell types. CK catalyses the conversion of creatine and uses adenosine triphosphate (ATP) to create phosphocreatine (PCr) and adenosine diphosphate (ADP). This CK enzyme reaction is reversible and thus ATP can be generated from PCr and ADP.
Blog Post

Simply Stated: RNA-Based Therapies in Development for Myotonic Dystrophy

By Sujatha Gurunathan | January 30, 2025
The United States Capitol building at sunset with reflection in water.
Blog Post

Championing for Change: MDA’s 2025 Advocacy Agenda

By Mark Fisher | January 28, 2025
Blog Post

Breaking Barriers in Higher Education: My Journey as a Student with Muscular Dystrophy

By Serena Desiderio | January 24, 2025
  • « Previous
  • 1
  • 2
  • 3
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1016 W Jackson Blvd #1073
Chicago, IL 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset